XYL

Xylem is a durable, essential-infrastructure franchise spanning four water segments (Water Infrastructure, Applied Water, Measurement & Control, Water Solutions & Services), and the FY2025 numbers show the post-Evoqua integration paying off in profitability. Operating income rose 21.2% to $1.22B versus revenue growth of only 5.5%, lifting operating margin to 13.5% and gross margin to 38.5% — clear operating leverage and mix improvement, not just acquired scale. Net income grew 7.5% to $957M with a 10.6% net margin. The auditor issued an unqualified opinion on both the financials and internal controls, and the MD&A frames Xylem as a leading global water technology company with recurring service and software (Xylem Vue) revenue layered on top of equipment.

The balance sheet is a genuine strength: liabilities/equity is just 0.51x, long-term debt fell 28.8% to $1.41B, cash rose 31.9% to $1.48B, and retained earnings grew 18.0% to $3.71B. Management is funding a growing dividend ($391M, +11.7%) comfortably. The cautionary notes are the deceleration in top-line growth (the FY21-FY24 ramp from $5.20B to $8.56B was largely the Evoqua acquisition; FY25's +5.5% is the more telling organic-era figure), a modest 8.3% ROE weighed down by a large goodwill-inflated equity base, operating cash flow that actually slipped 1.7% to $1.24B despite higher earnings (a working-capital/conversion watch item), and a current portion of debt that ballooned to $534M, signaling a near-term refinancing to monitor.